Rodent models of ADHD

Current Topics in Behavioral Neurosciences

Volumn 9, Issue , 2012, Pages 274-300

  Fan, Xueliang ^a   Bruno, Kristy J ^a   Hess, Ellen J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

6 Hydroxydopamine norepinephrine; Animal models; Coloboma mouse; Dopamine; Dopamine transporter knockout mouse; Serotonin; Spontaneously hypertensive rat

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR; DOPAMINE TRANSPORTER; MESSENGER RNA; NEUROKININ 1 RECEPTOR; NORADRENALIN; PSYCHOSTIMULANT AGENT; SEROTONIN; TYROSINE 3 MONOOXYGENASE; BIOGENIC AMINE;

ARTICLE; ATTENTION DEFICIT DISORDER; HUMAN; HYPERACTIVITY; HYPERTENSION; INTRACELLULAR SIGNALING; LOCOMOTION; MONOAMINERGIC SYSTEM; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DISEASE MODEL; GENETICS; METABOLISM; MOUSE; RAT;

ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIOGENIC MONOAMINES; DISEASE MODELS, ANIMAL; HUMANS; MICE; RATS; RECEPTORS, NEUROKININ-1;

EID: 84922481501     PISSN: 18663370     EISSN: 18663389     Source Type: Book Series    
DOI: 10.1007/7854_2011_121     Document Type: Article

References (142)

1. Akiyama K, Yabe K, Sutoo D (1992) Quantitative immunohistochemical distributions of tyrosine hydroxylase and calmodulin in the brains of spontaneously hypertensive rats. Kitasato Arch Exp Med 65:199-208
2. Archer T, FredrikssonA (2007) Behavioural supersensitivity following neonatal 6-hydroxydopamine: attenuation by MK-801. Neurotox Res 12:113-124
3. Archer T, Danysz W, Fredriksson A, Jonsson G, Luthman J, Sundstrom E, Teiling A (1988) Neonatal 6-hydroxydopamine-induced dopamine depletions: motor activity and performance in maze learning. Pharmacol Biochem Behav 31:357-364
4. Archer T, Palomo T, Fredriksson A (2002) Neonatal 6-hydroxydopamine-induced hypo/hyperactivity: blockade by dopamine reuptake inhibitors and effect of acute D-amphetamine. Neurotox Res 4:247-266
5. Avale ME, Falzone TL, Gelman DM, Low MJ, Grandy DK, Rubinstein M (2004a) The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder. Mol Psychiatry 9:718-726
6. Avale ME, Nemirovsky SI, Raisman-Vozari R, Rubinstein M (2004b) Elevated serotonin is involved in hyperactivity but not in the paradoxical effect of amphetamine in mice neonatally lesioned with 6-hydroxydopamine. J Neurosci Res 78:289-296
7. Barr CL, Feng Y, Wigg K, Bloom S, Roberts W, Malone M, Schachar R, Tannock R, Kennedy JL (2000) Identification of DNA variants in the SNAP-25 gene and linkage study of these polymorphisms and attention-deficit hyperactivity disorder. Mol Psychiatry 5:405-409
8. Barr AM, Lehmann-Masten V, Paulus M, Gainetdinov RR, Caron MG, Geyer MA (2004) The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout mice. Neuropsychopharmacology 29:221-228
9. Basura GJ, Walker PD (1999) Serotonin 2A receptor mRNA levels in the neonatal dopaminedepleted rat striatum remain upregulated following suppression of serotonin hyperinnervation. Brain Res Dev Brain Res 116:111-117
10. Bishop C, Tessmer JL, Ullrich T, Rice KC, Walker PD (2004) Serotonin 5-HT2A receptors underlie increased motor behaviors induced in dopamine-depleted rats by intrastriatal 5-HT2A/ 2C agonism. J Pharmacol Exp Ther 310:687-694
11. Bishop C, Daut GS, Walker PD (2005) Serotonin 5-HT2A but not 5-HT2C receptor antagonism reduces hyperlocomotor activity induced in dopamine-depleted rats by striatal administration of the D1 agonist SKF 82958. Neuropharmacology 49:350-358
12. Bizot JC, Chenault N, Houze B, Herpin A, David S, Pothion S, Trovero F (2007) Methylphenidate reduces impulsive behaviour in juvenile Wistar rats, but not in adult Wistar, SHR and WKY rats. Psychopharmacology (Berl) 193:215-223
13. Breese GR, Napier TC, Mueller RA (1985) Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats. J Pharmacol Exp Ther 234:447-455
14. Broaddus WC, Bennett JP Jr (1990) Postnatal development of striatal dopamine function. II. Effects of neonatal 6-hydroxydopamine treatments on D1 and D2 receptors, adenylate cyclase activity and presynaptic dopamine function. Brain Res Dev Brain Res 52:273-277
15. Bruno KJ, Hess EJ (2006) The alpha(2C)-adrenergic receptor mediates hyperactivity of coloboma mice, a model of attention deficit hyperactivity disorder. Neurobiol Dis 23:679-688
16. Bruno JP, Jackson D, Zigmond MJ, Stricker EM (1987) Effect of dopamine-depleting brain lesions in rat pups: role of striatal serotonergic neurons in behavior. Behav Neurosci 101:806-811
17. Bruno KJ, Freet CS, Twining RC, Egami K, Grigson PS, Hess EJ (2007) Abnormal latent inhibition and impulsivity in coloboma mice, a model of ADHD. Neurobiol Dis 25:206-216
18. Brus R, Kostrzewa RM, Perry KW, Fuller RW (1994) Supersensitization of the oral response to SKF 38393 in neonatal 6-hydroxydopamine-lesioned rats is eliminated by neonatal 5, 7-dihydroxytryptamine treatment. J Pharmacol Exp Ther 268:231-237
19. Brus R, Plech A, Kostrzewa RM (1995) Enhanced quinpirole response in rats lesioned neonatally with 5, 7-dihydroxytryptamine. Pharmacol Biochem Behav 50:649-653
20. Brus R, Nowak P, Szkilnik R, Mikolajun U, Kostrzewa RM (2004) Serotoninergics attenuate hyperlocomotor activity in rats. Potential new therapeutic strategy for hyperactivity. Neurotox Res 6:317-325
21. Budygin EA, Brodie MS, Sotnikova TD, Mateo Y, John CE, Cyr M, Gainetdinov RR, Jones SR (2004) Dissociation of rewarding and dopamine transporter-mediated properties of amphetamine. Proc Natl Acad Sci U S A 101:7781-7786
22. Butcher SP, Liptrot J, Aburthnott GW (1991) Characterisation of methylphenidate and nomifensine induced dopamine release in rat striatum using in vivo brain microdialysis. Neurosci Lett 122:245-248
23. Carboni E, Spielewoy C, Vacca C, Nosten-Bertrand M, Giros B, Di Chiara G (2001) Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene. J Neurosci 21: RC141: 141-144
24. Carboni E, Silvagni A, Valentini V, Di Chiara G (2003) Effect of amphetamine, cocaine and depolarization by high potassium on extracellular dopamine in the nucleus accumbens shell of SHR rats. An in vivo microdyalisis study. Neurosci Biobehav Rev 27:653-659
25. Castaneda E, Whishaw IQ, Lermer L, Robinson TE (1990) Dopamine depletion in neonatal rats: effects on behavior and striatal dopamine release assessed by intracerebral microdialysis during adulthood. Brain Res 508:30-39
26. Chiu P, Rajakumar G, Chiu S, Kwan CY, Mishra RK (1982) Enhanced [3H]spiroperidol binding in striatum of spontaneously hypertensive rat (SHR). Eur J Pharmacol 82:243-244
27. Chiu P, Rajakumar G, Chiu S, Kwan CY, Mishra RK (1984) Differential changes in central serotonin and dopamine receptors in spontaneous hypertensive rats. Prog Neuropsychopharmacol Biol Psychiatry 8:665-668
28. Dal Bo G, Berube-Carriere N, Mendez JA, Leo D, Riad M, Descarries L, Levesque D, Trudeau LE (2008) Enhanced glutamatergic phenotype of mesencephalic dopamine neurons after neonatal 6-hydroxydopamine lesion. Neuroscience 156:59-70
29. Davids E, Zhang K, Kula NS, Tarazi FI, Baldessarini RJ (2002) Effects of norepinephrine and serotonin transporter inhibitors on hyperactivity induced by neonatal 6-hydroxydopamine lesioning in rats. J Pharmacol Exp Ther 301:1097-1102
30. Dawson R Jr, Nagahama S, Oparil S (1987) Yohimbine-induced alterations of monoamine metabolism in the spontaneously hypertensive rat of the Okamoto strain (SHR). II. The central nervous system (CNS). Brain Res Bull 19:525-534
31. DeBruin NM, Kiliaan AJ, De Wilde MC, Broersen LM (2003) Combined uridine and choline administration improves cognitive deficits in spontaneously hypertensive rats. Neurobiol Learn Mem 80:63-79
32. DeFelipe C, Herrero JF, O'Brien JA, Palmer JA, Doyle CA, Smith AJH, Laird JMA, Belmonte C, Cervero F, Hunt SP (1998) Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature 392:394-397
33. deVilliers AS, Russell VA, Sagvolden T, Searson A, Jaffer A, Taljaard JJ (1995) Alpha 2-adrenoceptor mediated inhibition of [3H]dopamine release from nucleus accumbens slices and monoamine levels in a rat model for attention-deficit hyperactivity disorder. Neurochem Res 20:427-433
34. Dewar KM, Soghomonian JJ, Bruno JP, Descarries L, Reader TA (1990) Elevation of dopamine D2 but not D1 receptors in adult rat neostriatum after neonatal 6-hydroxydopamine denervation. Brain Res 536:287-296
35. Dewar KM, Paquet M, Reader TA (1997) Alterations in the turnover rate of dopamine D1 but not D2 receptors in the adult rat neostriatum after a neonatal dopamine denervation. Neurochem Int 30:613-621
36. Duncan GE, Criswell HE, McCown TJ, Paul IA, Mueller RA, Breese GR (1987) Behavioral and neurochemical responses to haloperidol and SCH-23390 in rats treated neonatally or as adults with 6-hydroxydopamine. J Pharmacol Exp Ther 243:1027-1034
37. Efron D, Jarman F, Barker M (1997) Methylphenidate versus dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial. Pediatrics 100:E6
38. Elia J, Borcherding BG, Rapoport JL, Keysor CS (1991) Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders? Psychiatry Res 36:141-155
39. Erinoff L, MacPhail RC, Heller A, Seiden LS (1979) Age-dependent effects of 6-hydroxydopamine on locomotor activity in the rat. Brain Res 164:195-205
40. Evenden J, Meyerson B (1999) The behavior of spontaneously hypertensive and Wistar Kyoto rats under a paced fixed consecutive number schedule of reinforcement. Pharmacol Biochem Behav 63:71-82
41. Fan X, Hess EJ (2007) D2-like dopamine receptors mediate the response to amphetamine in a mouse model of ADHD. Neurobiol Dis 26:201-211
42. Fan X, Xu M, Hess EJ (2010) D2 dopamine receptor subtype-mediated hyperactivity and amphetamine responses in a model of ADHD. Neurobiol Dis 37:228-236
43. Fauchey V, Jaber M, Caron MG, Bloch B, Le Moine C (2000) Differential regulation of the dopamine D1, D2 and D3 receptor gene expression and changes in the phenotype of the striatal neurons in mice lacking the dopamine transporter. Eur J Neurosci 12:19-26
44. Ferguson SA, Gough BJ, Cada AM (2003) In vivo basal and amphetamine-induced striatal dopamine and metabolite levels are similar in the spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley male rats. Physiol Behav 80:109-114
45. −/−mice. Eur J Neurosci 25:1195-1204
46. Fox AT, Hand DJ, Reilly MP (2008) Impulsive choice in a rodent model of attention-deficit/ hyperactivity disorder. Behav Brain Res 187:146-152
47. Froger N, Gardier AM, Moratalla R, Alberti I, Lena I, Boni C, De Felipe C, Rupniak NM, Hunt SP, Jacquot C, Hamon M, Lanfumey L (2001) 5-hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knock-out mice mimic antidepressantinduced desensitization. J Neurosci 21:8188-8197
48. Fujita S, Okutsu H, Yamaguchi H, Nakamura S, Adachi K, Saigusa T, Koshikawa N (2003) Altered pre-and postsynaptic dopamine receptor functions in spontaneously hypertensive rat: an animal model of attention-deficit hyperactivity disorder. J Oral Sci 45:75-83
49. Fuller RW, Hemrick-Luecke SK, Wong DT, Pearson D, Threlkeld PG, Hynes MD III (1983) Altered behavioral response to a D2 agonist, LY141865, in spontaneously hypertensive rats exhibiting biochemical and endocrine responses similar to those in normotensive rats. J Pharmacol Exp Ther 227:354-359
50. Gainetdinov RR, Jones SR, Fumagalli F, Wightman RM, Caron MG (1998) Re-evaluation of the role of the dopamine transporter in dopamine system homeostasis. Brain Res Brain Res Rev 26:148-153
51. Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG (1999) Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283:397-401
52. Garnock-Jones KP, Keating GM (2010) Spotlight on atomoxetine in attention-deficit hyperactivity disorder in children and adolescents. CNS Drugs 24:85-88
53. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379:606-612
54. Gong L, Kostrzewa RM, Fuller RW, Perry KW (1992) Supersensitization of the oral response to SKF 38393 in neonatal 6-OHDA-lesioned rats is mediated through a serotonin system. J Pharmacol Exp Ther 261:1000-1007
55. Gong L, Kostrzewa RM, Perry KW, Fuller RW (1993) Dose-related effects of a neonatal 6-OHDA lesion on SKF 38393-and m-chlorophenylpiperazine-induced oral activity responses of rats. Brain Res Dev Brain Res 76:233-238
56. Heal DJ, Smith SL, Kulkarni RS, Rowley HL (2008) New perspectives from microdialysis studies in freely-moving, spontaneously hypertensive rats on the pharmacology of drugs for the treatment of ADHD. Pharmacol Biochem Behav 90:184-197
57. Heffner TG, Seiden LS (1982) Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine. Brain Res 244:81-90
58. −/−) and wildtype mice: exploratory behaviour and extracellular noradrenaline concentration in the cerebral cortex of anaesthetized subjects. Neuropharmacology 48:706-719
59. Herrera-Marschitz M, Luthman J, Ferre S (1994) Unilateral neonatal intracerebroventricular 6-hydroxydopamine administration in rats: II. Effects on extracellular monoamine, acetylcholine and adenosine levels monitored with in vivo microdialysis. Psychopharmacology (Berl) 116:451-456
60. Hess EJ, Collins KA, Copeland NG, Jenkins NA, Wilson MC (1994) Deletion map of the coloboma (Cm) locus on mouse chromosome 2. Genomics 21:257-261
61. Hess EJ, Collins KA, Wilson MC (1996) Mouse model of hyperkinesis implicates SNAP-25 in behavioral regulation. J Neurosci 16:3104-3111
62. Howes LG, Rowe PR, Summers RJ, Louis WJ (1984) Age related changes of catecholamines and their metabolites in central nervous system regions of spontaneously hypertensive (SHR) and normotensive Wistar-Kyoto (WKY) rats. Clin Exp Hypertens A 6:2263-2277
63. Hynes MD, Langer DH, Hymson DL, Pearson DV, Fuller RW (1985) Differential effects of selected dopaminergic agents on locomotor activity in normotensive and spontaneously hypertensive rats. Pharmacol Biochem Behav 23:445-448
64. Ikegami M, Ichitani Y, Takahashi T, Iwasaki T (2006) Compensatory increase in extracellular dopamine in the nucleus accumbens of adult rats with neonatal 6-hydroxydopamine treatment. Nihon Shinkei Seishin Yakurigaku Zasshi 26:111-117
65. Jaber M, Dumartin B, Sagne C, Haycock JW, Roubert C, Giros B, Bloch B, Caron MG (1999) Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter. Eur J Neurosci 11:3499-3511
66. Jackson D, Abercrombie ED (1992) In vivo neurochemical evaluation of striatal serotonergic hyperinnervation in rats depleted of dopamine at infancy. J Neurochem 58:890-897
67. Jentsch JD (2005) Impaired visuospatial divided attention in the spontaneously hypertensive rat. Behav Brain Res 157:323-330
68. Johnson BJ, Bruno JP (1990) D1 and D2 receptor contributions to ingestive and locomotor behavior are altered after dopamine depletions in neonatal rats. Neurosci Lett 118:120-123
69. Jones MD, Hess EJ (2003) Norepinephrine regulates locomotor hyperactivity in the mouse mutant coloboma. Pharmacol Biochem Behav 75:209-216
70. Jones CR, Palacios JM, Hoyer D, Buhler FR (1990) Receptor modification in the brains of spontaneously hypertensive and Wistar-Kyoto rats: regionally specific and selective increase in cerebellar beta 2-adrenoceptors. Br J Clin Pharmacol 30(Suppl 1):174S-177S
71. Jones SR, Gainetdinov RR, Wightman RM, Caron MG (1998) Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J Neurosci 18:1979-1986
72. Jones SR, Gainetdinov RR, Hu XT, Cooper DC, Wightman RM, White FJ, Caron MG (1999) Loss of autoreceptor functions in mice lacking the dopamine transporter. Nat Neurosci 2:649-655
73. Jones MD, Williams ME, Hess EJ (2001a) Abnormal presynaptic catecholamine regulation in a hyperactive SNAP-25-deficient mouse mutant. Pharmacol Biochem Behav 68:669-676
74. Jones MD, Williams ME, Hess EJ (2001b) Expression of catecholaminergic mRNAs in the hyperactive mouse mutant coloboma. Brain Res Mol Brain Res 96:114-121
75. Kirouac GJ, Ganguly PK (1993) Up-regulation of dopamine receptors in the brain of the spontaneously hypertensive rat: an autoradiographic analysis. Neuroscience 52:135-141
76. Kirouac GJ, Ganguly PK (1995) Cholecystokinin-induced release of dopamine in the nucleus accumbens of the spontaneously hypertensive rat. Brain Res 689:245-253
77. Kostrzewa RM, Gong L, Brus R (1993) Serotonin (5-HT) systems mediate dopamine (DA) receptor supersensitivity. Acta Neurobiol Exp (Wars) 53:31-41
78. Kostrzewa RM, Brus R, Kalbfleisch JH, Perry KW, Fuller RW (1994) Proposed animal model of attention deficit hyperactivity disorder. Brain Res Bull 34:161-167
79. Kustanovich V, Merriman B, McGough J, McCracken JT, Smalley SL, Nelson SF (2003) Biased paternal transmission of SNAP-25 risk alleles in attention-deficit hyperactivity disorder. Mol Psychiatry 8:309-315
80. LeFur G, Guilloux F, Uzan A (1983) Evidence for an increase in [3H]spiperone binding in hypothalamic nuclei during the development of spontaneous hypertension in the rat. Clin Exp Hypertens A 5:1537-1542
81. Li B, Arime Y, Hall FS, Uhl GR, Sora I (2010) Impaired spatial working memory and decreased frontal cortex BDNF protein level in dopamine transporter knockout mice. Eur J Pharmacol 628:104-107
82. Lim DK, Ito Y, Hoskins B, Rockhold RW, Ho IK (1989) Comparative studies of muscarinic and dopamine receptors in three strains of rat. Eur J Pharmacol 165:279-287
83. Linthorst AC, Van den Buuse M, De Jong W, Versteeg DH (1990) Electrically stimulated [3H] dopamine and [14C]acetylcholine release from nucleus caudatus slices: differences between spontaneously hypertensive rats and Wistar-Kyoto rats. Brain Res 509:266-272
84. Linthorst AC, De Lang H, De Jong W, Versteeg DH (1991) Effect of the dopamine D2 receptor agonist quinpirole on the in vivo release of dopamine in the caudate nucleus of hypertensive rats. Eur J Pharmacol 201:125-133
85. Linthorst AC, Broekhoven MH, De Jong W, Van Wimersma Greidanus TB, Versteeg DH (1992) Effect of SCH 23390 and quinpirole on novelty-induced grooming behaviour in spontaneously hypertensive rats and Wistar-Kyoto rats. Eur J Pharmacol 219:23-28
86. Linthorst AC, De Jong W, De Boer T, Versteeg DH (1993) Dopamine D1 and D2 receptors in the caudate nucleus of spontaneously hypertensive rats and normotensive Wistar-Kyoto rats. Brain Res 602:119-125
87. Liu LL, Yang J, Lei GF, Wang GJ, Wang YW, Sun RP (2008) Atomoxetine increases histamine release and improves learning deficits in an animal model of attention-deficit hyperactivity disorder: the spontaneously hypertensive rat. Basic Clin Pharmacol Toxicol 102:527-532
88. Loupe PS, Zhou X, Davies MI, Schroeder SR, Tessel RE, Lunte SM (2002) Fixed ratio discrimination training increases in vivo striatal dopamine in neonatal 6-OHDA-lesioned rats. Pharmacol Biochem Behav 74:61-71
89. Lubow RE, Josman ZE (1993) Latent inhibition deficits in hyperactive children. J Child Psychol Psychiatry 34:959-973
90. Luque JM, Guillamon A, Hwang BH (1991) Quantitative autoradiographic study on tyrosine hydroxylase mRNA with in situ hybridization and alpha 2 adrenergic receptor binding in the locus coeruleus of the spontaneously hypertensive rat. Neurosci Lett 131:163-166
91. Luthman J, Fredriksson A, Lewander T, Jonsson G, Archer T (1989a) Effects of d-amphetamine and methylphenidate on hyperactivity produced by neonatal 6-hydroxydopamine treatment. Psychopharmacology (Berl) 99:550-557
92. Luthman J, Fredriksson A, Sundstrom E, Jonsson G, Archer T (1989b) Selective lesion of central dopamine or noradrenaline neuron systems in the neonatal rat: motor behavior and monoamine alterations at adult stage. Behav Brain Res 33:267-277
93. Luthman J, Brodin E, Sundstrom E, Wiehager B (1990a) Studies on brain monoamine and neuropeptide systems after neonatal intracerebroventricular 6-hydroxydopamine treatment. Int J Dev Neurosci 8:549-560
94. Luthman J, Lindqvist E, Young D, Cowburn R (1990b) Neonatal dopamine lesion in the rat results in enhanced adenylate cyclase activity without altering dopamine receptor binding or dopamine-and adenosine 3':5'-monophosphate-regulated phosphoprotein (DARPP-32) immunoreactivity. Exp Brain Res 83:85-95
95. Luthman J, Friedemann M, Bickford P, Olson L, Hoffer BJ, Gerhardt GA (1993a) In vivo electrochemical measurements and electrophysiological studies of rat striatum following neonatal 6-hydroxydopamine treatment. Neuroscience 52:677-687
96. Luthman J, Friedemann MN, Hoffer BJ, Gerhardt GA (1993b) In vivo electrochemical measurements of exogenous dopamine clearance in normal and neonatal 6-hydroxydopamine-treated rat striatum. Exp Neurol 122:273-282
97. Luthman J, Lindqvist E, Ogren SO (1995) Hyperactivity in neonatally dopamine-lesioned rats requires residual activity in mesolimbic dopamine neurons. Pharmacol Biochem Behav 51:159-163
98. Luthman J, Friedemann MN, Hoffer BJ, Gerhardt GA (1997) In vivo electrochemical measurements of serotonin clearance in rat striatum: effects of neonatal 6-hydroxydopamine-induced serotonin hyperinnervation and serotonin uptake inhibitors. J Neural Transm 104:379-397
99. Masuo Y, Ishido M, Morita M, Oka S, Niki E (2004) Motor activity and gene expression in rats with neonatal 6-hydroxydopamine lesions. J Neurochem 91:9-19
100. Mill J, Curran S, Kent L, Gould A, Huckett L, Richards S, Taylor E, Asherson P (2002) Association study of a SNAP-25 microsatellite and attention deficit hyperactivity disorder. Am J Med Genet 114:269-271
101. Miller FE, Heffner TG, Kotake C, Seiden LS (1981) Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion. Brain Res 229:123-132
102. Molina-Holgado E, Dewar KM, Descarries L, Reader TA (1994) Altered dopamine and serotonin metabolism in the dopamine-denervated and serotonin-hyperinnervated neostriatum of adult rat after neonatal 6-hydroxydopamine. J Pharmacol Exp Ther 270:713-721
103. Moran-Gates T, Zhang K, Baldessarini RJ, Tarazi FI (2005) Atomoxetine blocks motor hyperactivity in neonatal 6-hydroxydopamine-lesioned rats: implications for treatment of attentiondeficit hyperactivity disorder. Int J Neuropsychopharmacol 8:439-444
104. Myers MM, Whittemore SR, Hendley ED (1981) Changes in catecholamine neuronal uptake and receptor binding in the brains of spontaneously hypertensive rats (SHR). Brain Res 220:325-338
105. Myers MM, Musty RE, Hendley ED (1982) Attenuation of hyperactivity in the spontaneously hypertensive rat by amphetamine. Behav Neural Biol 34:42-54
106. Nowak P, Bortel A, Dabrowska J, Oswiecimska J, DrosikM, Kwiecinski A, Opara J, Kostrzewa RM, Brus R (2007) Amphetamine and mCPP effects on dopamine and serotonin striatal in vivo microdialysates in an animal model of hyperactivity. Neurotox Res 11:131-144
107. Oke AF, Adams RN (1978) Selective attention dysfunctions in adult rats neonatally treated with 6-hydoxydopamine. Pharmacol Biochem Behav 9:429-432
108. Papa M, Diewald L, CareyMP, Esposito FJ, Gironi Carnevale UA, Sadile AG (2002)A rostro-caudal dissociation in the dorsal and ventral striatum of the juvenile SHR suggests an anterior hypo-and a posterior hyperfunctioning mesocorticolimbic system. Behav Brain Res 130:171-179
109. Raber J, Mehta PP, Kreifeldt M, Parsons LH, Weiss F, Bloom FE, Wilson MC (1997) Coloboma hyperactive mutant mice exhibit regional and transmitter-specific deficits in neurotransmission. J Neurochem 68:176-186
110. Radja F, Descarries L, Dewar KM, Reader TA (1993) Serotonin 5-HT1 and 5-HT2 receptors in adult rat brain after neonatal destruction of nigrostriatal dopamine neurons: a quantitative autoradiographic study. Brain Res 606:273-285
111. Raison S, Weissmann D, Rousset C, Pujol JF, Descarries L (1995) Changes in steady-state levels of tryptophan hydroxylase protein in adult rat brain after neonatal 6-hydroxydopamine lesion. Neuroscience 67:463-475
112. Russell VA (2000) The nucleus accumbens motor-limbic interface of the spontaneously hypertensive rat as studied in vitro by the superfusion slice technique. Neurosci Biobehav Rev 24:133-136
113. Russell VA (2002) Hypodopaminergic and hypernoradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder-the spontaneously hypertensive rat. Behav Brain Res 130:191-196
114. Russell V, de Villiers A, Sagvolden T, Lamm M, Taljaard J (1998) Differences between electrically-, ritalin-and D-amphetamine-stimulated release of [3H]dopamine from brain slices suggest impaired vesicular storage of dopamine in an animal model of Attention-Deficit Hyperactivity Disorder. Behav Brain Res 94:163-171
115. Russell V, Allie S, Wiggins T (2000) Increased noradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder-the spontaneously hypertensive rat. Behav Brain Res 117:69-74
116. Sadile AG (2000) Multiple evidence of a segmental defect in the anterior forebrain of an animal model of hyperactivity and attention deficit. Neurosci Biobehav Rev 24:161-169
117. Sagvolden T (2006) The alpha-2A adrenoceptor agonist guanfacine improves sustained attention and reduces overactivity and impulsiveness in an animalmodel ofAttention-Deficit/Hyperactivity Disorder (ADHD). Behav Brain Funct 2:41
118. Sagvolden T, Metzger MA, Schiorbeck HK, Rugland AL, Spinnangr I, Sagvolden G (1992) The spontaneously hypertensive rat (SHR) as an animal model of childhood hyperactivity (ADHD): changed reactivity to reinforcers and to psychomotor stimulants. Behav Neural Biol 58:103-112
119. Sagvolden T, Aase H, Zeiner P, Berger D (1998) Altered reinforcement mechanisms in attentiondeficit/ hyperactivity disorder. Behav Brain Res 94:61-71
120. Santarelli L, Gobbi G, Debs PC, Sibille ET, Blier P, Hen R, Heath MJ (2001) Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function. Proc Natl Acad Sci USA 98:1912-1917
121. Shaywitz BA, Klopper JH, Yager RD, Gordon JW (1976a) Paradoxical response to amphetamine in developing rats treated with 6-hydroxydopamine. Nature 261:153-155
122. Shaywitz BA, Yager RD, Klopper JH (1976b) Selective brain dopamine depletion in developing rats: an experimental model of minimal brain dysfunction. Science 191:305-308
123. Shaywitz BA, Klopper JH, Gordon JW (1978) Methylphenidate in 6-hydroxydopamine-treated developing rat pups. Effects on activity and maze performance. Arch Neurol 35:463-469
124. Shen HW, Hagino Y, Kobayashi H, Shinohara-Tanaka K, Ikeda K, Yamamoto H, Yamamoto T, Lesch KP, Murphy DL, Hall FS, Uhl GR, Sora I (2004) Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters. Neuropsychopharmacology 29:1790-1799
125. Snyder AM, Zigmond MJ, Lund RD (1986) Sprouting of serotoninergic afferents into striatum after dopamine-depleting lesions in infant rats: a retrograde transport and immunocytochemical study. J Comp Neurol 245:274-281
126. Sora I, Wichems C, Takahashi N, Li XF, Zeng Z, Revay R, Lesch KP, Murphy DL, Uhl GR (1998) Cocaine reward models: conditioned place preference can be established in dopamine-and in serotonin-transporter knockout mice. Proc Natl Acad Sci U S A 95:7699-7704
127. Spielewoy C, Roubert C, Hamon M, Nosten-Bertrand M, Betancur C, Giros B (2000) Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice. Behav Pharmacol 11:279-290
128. Stachowiak MK, Bruno JP, Snyder AM, Stricker EM, Zigmond MJ (1984) Apparent sprouting of striatal serotonergic terminals after dopamine-depleting brain lesions in neonatal rats. Brain Res 291:164-167
129. Sulzer D, Chen TK, Lau YY, Kristensen H, Rayport S, Ewing A (1995) Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J Neurosci 15:4102-4108
130. Towle AC, Criswell HE, Maynard EH, Lauder JM, Joh TH, Mueller RA, Breese GR (1989) Serotonergic innervation of the rat caudate following a neonatal 6-hydroxydopamine lesion: an anatomical, biochemical and pharmacological study. Pharmacol Biochem Behav 34: 367-374
131. Tsuda K, Tsuda S, Masuyama Y, Goldstein M (1990) Norepinephrine release and neuropeptide Y in medulla oblongata of spontaneously hypertensive rats. Hypertension 15:784-790
132. van denBuuse M, de Jong W (1989) Differential effects of dopaminergic drugs on open-field behavior of spontaneously hypertensive rats and normotensive Wistar-Kyoto rats. J Pharmacol Exp Ther 248:1189-1196
133. van denBuuse M, Linthorst AC, Versteeg DH, de JongW (1991) Role of brain dopamine systems in the development of hypertension in the spontaneously hypertensive rat. Clin Exp Hypertens A 13:653-659
134. van denBuuse M, Jones CR, Wagner J (1992) Brain dopamine D-2 receptor mechanisms in spontaneously hypertensive rats. Brain Res Bull 28:289-297
135. Wultz B, Sagvolden T, Moser EI, Moser MB (1990) The spontaneously hypertensive rat as an animal model of attention-deficit hyperactivity disorder: effects of methylphenidate on exploratory behavior. Behav Neural Biol 53:88-102
136. Yamada S, Ashizawa N, Nakayama K, Tomita T, Hayashi E (1989) Decreased density of alpha 2-adrenoceptors in medulla oblongata of spontaneously hypertensive rats. J Cardiovasc Pharmacol 13:440-446
137. Yan TC, Hunt SP, Stanford SC (2009) Behavioural and neurochemical abnormalities in mice lacking functional tachykinin-1 (NK1) receptors: a model of attention deficit hyperactivity disorder. Neuropharmacology 57:627-635
138. Yan TC, McQuillin A, Thapar A, Asherson P, Hunt SP, Stanford SC, Gurling H (2010) NK1 (TACR1) receptor gene 'knockout' mouse phenotype predicts genetic association with ADHD. J Psychopharmacol 24:27-38
139. Yousfi-Alaoui MA, Hospital S, Garcia-Sanz A, Badia A, Clos MV (2001) Presynaptic modulation of K+-evoked [3H]dopamine release in striatal and frontal cortical synaptosomes of normotensive and spontaneous-hypertensive rats. Neurochem Res 26:1271-1275
140. Zhang K, Davids E, Tarazi FI, Baldessarini RJ (2002a) Serotonin transporter binding increases in caudate-putamen and nucleus accumbens after neonatal 6-hydroxydopamine lesions in rats: implications for motor hyperactivity. Brain Res Dev Brain Res 137:135-138
141. Zhang K, Tarazi FI, Davids E, Baldessarini RJ (2002b) Plasticity of dopamine D4 receptors in rat forebrain: temporal association with motor hyperactivity following neonatal 6-hydroxydopamine lesioning. Neuropsychopharmacology 26:625-633
142. Zhuang X, Oosting RS, Jones SR, Gainetdinov RR, Miller GW, Caron MG, Hen R (2001) Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proc Natl Acad Sci U S A 98:1982-1987